1. Home
  2. GBIO vs UONE Comparison

GBIO vs UONE Comparison

Compare GBIO & UONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • UONE
  • Stock Information
  • Founded
  • GBIO 2016
  • UONE 1980
  • Country
  • GBIO United States
  • UONE United States
  • Employees
  • GBIO N/A
  • UONE N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • UONE Broadcasting
  • Sector
  • GBIO Health Care
  • UONE Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • UONE Nasdaq
  • Market Cap
  • GBIO 64.8M
  • UONE 69.5M
  • IPO Year
  • GBIO 2020
  • UONE N/A
  • Fundamental
  • Price
  • GBIO $0.78
  • UONE $1.34
  • Analyst Decision
  • GBIO Strong Buy
  • UONE
  • Analyst Count
  • GBIO 2
  • UONE 0
  • Target Price
  • GBIO $6.50
  • UONE N/A
  • AVG Volume (30 Days)
  • GBIO 649.2K
  • UONE 26.5K
  • Earning Date
  • GBIO 03-05-2025
  • UONE 11-12-2024
  • Dividend Yield
  • GBIO N/A
  • UONE N/A
  • EPS Growth
  • GBIO N/A
  • UONE N/A
  • EPS
  • GBIO N/A
  • UONE N/A
  • Revenue
  • GBIO $18,582,000.00
  • UONE $452,891,000.00
  • Revenue This Year
  • GBIO $212.74
  • UONE N/A
  • Revenue Next Year
  • GBIO N/A
  • UONE N/A
  • P/E Ratio
  • GBIO N/A
  • UONE N/A
  • Revenue Growth
  • GBIO 514.08
  • UONE N/A
  • 52 Week Low
  • GBIO $0.72
  • UONE $1.23
  • 52 Week High
  • GBIO $4.65
  • UONE $3.88
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 29.26
  • UONE 39.03
  • Support Level
  • GBIO $0.72
  • UONE $1.47
  • Resistance Level
  • GBIO $1.00
  • UONE $1.41
  • Average True Range (ATR)
  • GBIO 0.07
  • UONE 0.08
  • MACD
  • GBIO -0.00
  • UONE -0.01
  • Stochastic Oscillator
  • GBIO 18.68
  • UONE 8.82

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About UONE Urban One Inc.

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: